Evidence map›Paper›PMID 24945934›Full record

ArticlePloS one2014

Colonic immune suppression, barrier dysfunction, and dysbiosis by gastrointestinal bacillus anthracis Infection.

Yaíma L Lightfoot, Tao Yang, Bikash Sahay, Mojgan Zadeh, Sam X Cheng, Gary P Wang, Jennifer L Owen, Mansour Mohamadzadeh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. New insights into gastrointestinal anthrax infection.Trends in molecular medicine · 2015
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yaíma L LightfootDepartment of Infectious Diseases and Pathology, University of Florida, Gainesville, Florida, United States of America; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
Tao YangDepartment of Infectious Diseases and Pathology, University of Florida, Gainesville, Florida, United States of America; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
Bikash SahayDepartment of Infectious Diseases and Pathology, University of Florida, Gainesville, Florida, United States of America; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
Mojgan ZadehDepartment of Infectious Diseases and Pathology, University of Florida, Gainesville, Florida, United States of America; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
Sam X ChengDivision of Gastroenterology, Department of Pediatrics, University of Florida, Gainesville, Florida, United States of America.
Gary P WangDivision of Infectious Diseases and Global Medicine, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
Jennifer L OwenDepartment of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, United States of America.
Mansour MohamadzadehDepartment of Infectious Diseases and Pathology, University of Florida, Gainesville, Florida, United States of America; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, Florida, United States of America.
University of Florida · US

Funding

Novel multivalent vaccine for anthrax and botulinumR01AI093370 · NIAID · UNIVERSITY OF FLORIDA · PI ZADEH, MANSOUR M · 2011 to 2015
$3.2M
NIAID NIH HHS R01 AI093370
6 · The paper itself

Abstract

Gastrointestinal (GI) anthrax results from the ingestion of Bacillus anthracis. Herein, we investigated the pathogenesis of GI anthrax in animals orally infected with toxigenic non-encapsulated B. anthracis Sterne strain (pXO1+ pXO2-) spores that resulted in rapid animal death. B. anthracis Sterne induced significant breakdown of intestinal barrier function and led to gut dysbiosis, resulting in systemic dissemination of not only B. anthracis, but also of commensals. Disease progression significantly correlated with the deterioration of innate and T cell functions. Our studies provide critical immunologic and physiologic insights into the pathogenesis of GI anthrax infection, whereupon cleavage of mitogen-activated protein kinases (MAPKs) in immune cells may play a central role in promoting dysfunctional immune responses against this deadly pathogen.

Indexed as

Immune ToleranceAnimalsAnthraxBacillus anthracisColonDysbiosisEpitheliumGastrointestinal DiseasesImmunity, InnateMiceMitogen-Activated Protein KinasesT-LymphocytesMitogen-Activated Protein Kinases

Identifiers

PMID24945934
PMCPMC4063899
OpenAlexW2041722698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.